3/20
04:19 pm
xtlb
XTL Biopharmaceuticals announces 1-for-4 ADS ratio change [Seeking Alpha]
Low
Report
XTL Biopharmaceuticals announces 1-for-4 ADS ratio change [Seeking Alpha]
3/20
04:10 pm
xtlb
XTL Biopharmaceuticals Announces ADS Ratio Change
Low
Report
XTL Biopharmaceuticals Announces ADS Ratio Change
3/10
08:04 am
xtlb
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. [Yahoo! Finance]
High
Report
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. [Yahoo! Finance]
2/27
04:30 pm
xtlb
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
Low
Report
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
1/29
04:05 pm
xtlb
XTL Update on Recent Developments
Low
Report
XTL Update on Recent Developments
1/23
04:30 pm
xtlb
XTL announces receipt of Nasdaq notification [Seeking Alpha]
High
Report
XTL announces receipt of Nasdaq notification [Seeking Alpha]
1/23
04:10 pm
xtlb
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
Medium
Report
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
1/13
02:18 pm
xtlb
Top Midday Gainers [Yahoo! Finance]
Low
Report
Top Midday Gainers [Yahoo! Finance]
1/13
09:28 am
xtlb
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
High
Report
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership